Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain fuel mystery: can glucagon change how we think?

NCT ID NCT07350512

First seen Jan 27, 2026 · Last updated Jun 23, 2026 · Updated 31 times

Summary

This pilot study will test how the hormone glucagon affects brain activity and sugar use in 15 healthy adults. Participants receive an alanine infusion to raise glucagon levels, while researchers measure changes in blood sugar and cognitive function. The goal is to understand basic biology, not to treat any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLUCOSE METABOLISM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg

    Copenhagen, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

alanine

What this could lead to

If successful, this could reveal how glucagon influences brain energy use and thinking, potentially guiding future research into metabolic brain disorders.

What could go wrong

This is a very small pilot study in healthy people, so results may not apply to patients. It only looks at short-term effects and does not test any treatment.

Conditions

The condition(s) this trial relates to.

glucose metabolism disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.